A thirteen week dietary toxicity study with 7-hydroxymatairesinol potassium acetate (HMRlignan) in rats

Regulatory Toxicology and Pharmacology

Volumn 41, Issue 1, 2005, Pages 28-38

  Lina, B ^a   Korte, H ^b   Nyman, L ^b   Unkila, M ^b  

^a TNO   (Netherlands)

^b Finland   (Finland)

Author keywords

7 Hydroxymatairesinol; Enterolactone; Lignan; Safety; Sub chronic; Toxicity

Indexed keywords

7 HYDROXYENTEROLACTONE; 7 HYDROXYMATAIRESINOL POTASSIUM ACETATE; DRUG METABOLITE; ENTEROLACTONE; LIGNAN; MATAIRESINOL; PHOSPHOLIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHRONIC TOXICITY; COGNITION; CONTROLLED STUDY; DIET; DOSE RESPONSE; DRUG BLOOD LEVEL; ESTRUS CYCLE; FEMALE; FOOD INTAKE; HISTOPATHOLOGY; KIDNEY DISEASE; LEUKOCYTE COUNT; MALE; MOTOR ACTIVITY; NONHUMAN; OPHTHALMOSCOPY; ORGAN WEIGHT; OVARY; PALATABILITY; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; THROMBOCYTE COUNT; TOXICITY TESTING; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

4-BUTYROLACTONE; ANIMALS; BODY WEIGHT; DIET; FEMALE; LIGNANS; MALE; MOTOR ACTIVITY; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; POTASSIUM ACETATE; RATS; RATS, WISTAR;

MAMMALIA; RATTUS NORVEGICUS;

EID: 11844263935     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yrtph.2004.09.001     Document Type: Article

References (42)

1. H. Adlercreutz, K. Hockerstedt, C. Bannwart, S. Bloigu, E. Hämäläinen, and A. Ollus Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG) J. Steroid. Biochem. Mol. Biol. 27 1987 1135 1144
2. H. Adlercreutz Phytoestrogens and cancer Lancet Oncol. 3 2002 364 373
3. M. Axelson, J. Sjövall, B.E. Gustafsson, and K.D.R. Setchell Origin of lignans in mammals and identification of a precursor in plants Nature 298 1982 659 660
4. S.J. Borghoff Alpha2u-globulin-mediated male rat nephropathy and kidney cancer: relevance to human risk assessment CIIT Activ. 13 4 1993 1 8
5. A.P. DeGroot, H.P. Til, V.J. Feron, H.C. Dreef van der Meulen, and M.I. Willems Two-year feeding and multigeneration studies in rats in five chemically modified starches Food Cosmet. Toxicol. 12 1974 651 663
6. S.K. Durham, and J.A. Swenberg Chapter 17. Risk assessment: the changing paradigm W.M. Haschek C.G. Rousseaux M.A. Wallig Handbook of Toxicologic Pathology second ed. 1974 Academic Press San Diego 441
7. R. Ekman Analysis of lignans in norway spruce by combined gas chromatography-mass spectrometry Holzforschung 30 1976 79 85
8. V.J. Feron, A.P. de Groot, M.T. Spanjers, and H.P. Til An evaluation of the criterion 'organ weight' under conditions of growth retardation Food Cosmet. Toxicol. 11 1973 85 94
9. FDA Guidelines for Toxicological testing (1982). Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food. US Food and Drug Administration Bureau of Foods
10. P. Greaves Chapter IX. Urinary tract Histopathology of Preclinical Toxicity Studies 1990 Elsevier Amsterdam 534
11. D. Ingram, K. Sanders, M. Kolybaba, and D. Lopez Case-control study of phyto-oestrogens and breast cancer Lancet 350 1997 990 994
12. Kennel, P., Pallen, C., Barale-Thomas, E., Espuna, G., Bars, R., 2004. Tamoxifen: 28 day oral toxicity study in the rat based on the Enhanced OECD Test Guideline 407 to detect endocrine effects. Arch. Toxicol. 77, 487-499
13. Lina, B.A.R., 2002. Sub-chronic (13-week) oral toxicity study with HM-3000 in rats. TNO report V4213
14. G.C. Long, I.R. Cohen, C.L. Gries, J.K. Young, P.C. Francis, and C.C. Capen Proliferative lesions of ovarian granulosa cells and reversible hormonal changes induced in rats by a selective estrogen receptor modulator Toxicol. Pathol. 29 2001 403 410
15. B.S. Lynch, A.S. Tischler, C. Capen, I.C. Munro, L.M. McGirr, and R.M. McClain Low digestible carbohydrates (polyols and lactose): significance of adrenal medullary proliferative lesions in the rat Regul. Toxicol. Pharmacol. 23 1996 256 297
16. V. Mazur, and H. Adlercreutz Natural and anthropogenic environmental oestrogens: the scientific basis for risk assessment. Naturally occurring oestrogens in food Pure Appl. Chem. 70 1998 1759 1776
17. V. Mazur, and H. Adlercreutz Overview of naturally occurring endocrine-active substances in the human diet in relation to human health Nutrition 16 2000 654 687
18. S. McCann, K. Moysich, J. Freudheim, C. Ambrosone, and P. Shields The risk of breast cancer associated with dietary lignans differs by CYP17 geotype in women J. Nutr. 132 2002 3036 3041
19. L.P. Meagher, and G.R. Beecher Assessment of data on lignan content of foods J. Food Compos. Anal. 13 2000 935 947
20. H. Nagahori, K. Kamai, Y. Tomigahara, K, N. Isobe, and H. Kaneko Initial induction and subsequent reduction of alpha(2u)-globulin in urine and serum of mature male rats after repeated intraperitoneal injections of (anti)estrogen Toxicology 162 2001 73 80
21. L.J. Orcheson, S.E. Rickard, M.M. Seidl, and L.U. Thompson Flaxseed and its mammalian lignan precursor cause a lengthening or cessation of estrous cycling in rats Cancer Lett. 125 1998 69 76
22. OECD, 1998. Guideline for the Testing of Chemicals 408 Repeated Dose 90-day Oral Toxicity Studying Rodents. OECD, Paris
23. OECD, 1998. OECD Principles of Good Laboratory Practice ENV/MC/CHEM (98) 17. OECD, Paris
24. S. Oikarinen, A.-M. Pajari, and M. Mutanen Chemopreventive activity of crude hydroxymatairesinol (HMR) extract in APCmin mice Cancer Lett. 161 2000 253 258
25. S. Oishi, H. Oishi, and K. Higara The effect of food restriction for 4 weeks on common toxicity parameters in male rats Toxicol. Appl. Pharmacol. 47 1979 15 22
26. Peñalvo, J.L., Heinonen, M., Deyama, S., Nishibe, S., Adlercreutz, H., 2003. Characterization of sesame (sesamum indicum I.) seed lignans. (Karlsruhe 8th Nutrition Congress, Oct 12-14, 2003, Karlsruhe, Germany), abstract book p. 63
27. P. Pietinen, K. Stumpf, S. Männistö, V. Kataja, M. Uusitupa, and H. Adlercreutz Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland Cancer Epidemiol. Biomarkers Prev. 10 2001 339 344
28. K. Prasad Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone Int. Angiol. 9 2000 220 225
29. N.M. Saarinen, A. Wärri, S.I. Mäkalä, C. Eckerman, M. Reunanen, M. Ahotupa, S.M. Salmi, A.A. Franke, L. Kangas, and R. Santti Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies) Nutr. Cancer Res. 36 2000 207 216
30. N.M. Saarinen, R. Huovinen, A. Wärri, S. Mäkelä, L. Valentín-Blasini, R. Sjöholm, J. Ämmälä, R. Lehtilä, C. Eckerman, Y.U. Collan, and R. Santti Enterolactone inhibits the growth of 7,12-dimethylbenz[a]anthracene-induced mammary carcinomas in rats Mol. Cancer Ther. 1 2002 869 876
31. W. Scheppach Effects of short chain fatty acids on gut morphology and function Gut Suppl. 1 1994 S35 38
32. M. Schöttner, and G. Spiteller Lignans interfering with 5-alpha.dihydrotestosterone binding to human sex hormone-binding globulin J. Nat. Prod. 61 1998 119 121
33. J.A. Swenberg, S. Short, S. Borghof, J. Strasser, and M. Charbonneau The comparative pathobiology of alpha2-u-globulin nepropathy Toxicol. Appl. Pharmacol. 97 1989 35 46
34. J.C. Tou, J. Chen, and L.U. Thompson Flaxseed, and its lignan precursor, secoisolarcisiresinol- diglycoside, affect pregnancy outcome and reproductive performance in rats J. Nutr. 128 1998 1861 1868
35. J.C. Tou, and L.U. Thompson Exposure to flaxseed or its lignan component during different developmental stages influences mammary gland structures Carcinogenesis 20 1999 1831 1835
36. M. Vanharanta, S. Voutilainen, T.A. Lakka, M. van der Lee, H. Aldercreutz, and J.T. Salonen Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study Lancet 354 1999 2112 2115
37. M. Vanharanta, S. Voutilainen, T. Nurmi, J. Kaikkonen, L.J. Roberts, J.D. Morrow, H. Aldercreutz, and J.T. Salonen Association between low serum enterolactone and increased plasma F2 isoprostanes, a measure of lipid peroxidation Atherosclerosis 160 2002 465 469
38. M. Vanharanta, S. Voutilainen, T.H. Rissanen, H. Adlercreutz, and J.T. Salonen Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone. Kuopio ischaemic heart disease risk factor study Arch. Intern. Med. 163 2003 1099 1104
39. A.P.M Wolterbeek, A. Roberts, H. Korte, M. Unkila, and D.-H. Waalkens-Berendsen Prenatal developmental toxicity study with 7-hydroxymatairesinol potassium acetate (HMRlignan) in rats Regul. Toxicol. Pharmacol. 40 2004 1 8
40. C. Wang, T. Makela, T. Hase, H. Adlercreutz, and M.S. Kurzer Lignans and flavonoids inhibit aromatase activity in human preadipocytes J. Steroid. Biochem. Mol. Biol. 50 1994 205 212
41. L-Q. Wang Mammalian phytoestrogens: enterodiol and enterolactone J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002 777:289
42. WHO, 1987. Principles for the Safety Assessment of Food Additives and Contaminants in Food. World Health Organization (WHO), International Programme on Chemical Safety (IPCS); Geneva. Environmental Health Criteria, No. 70, 39-56